Terumo (OTCMKTS:TRUMY) Shares Gap Up on Better-Than-Expected Earnings

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped up prior to trading on Monday following a better than expected earnings announcement. The stock had previously closed at $14.54, but opened at $16.14. Terumo shares last traded at $16.19, with a volume of 4,271 shares.

The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.13. Terumo had a return on equity of 10.55% and a net margin of 13.83%.The business had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.84 billion.

Wall Street Analyst Weigh In

Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Terumo has an average rating of “Buy”.

Terumo Trading Up 11.3%

The firm has a market capitalization of $23.88 billion, a PE ratio of 22.80 and a beta of 0.68. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. The business has a fifty day moving average price of $14.00 and a two-hundred day moving average price of $13.56.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.